Add to ORKGA procedure is described for the accelerator production of 232pa and its isolation in radio-chemically pdre form, suitable for isotope tracing of protact inium/thorium chemical separations
Cross sections have been measured for the production of actinium isotopes (224 to 228) in the bombar...
The science of cancer research is currently expanding its use of alpha particle emitting radioisotop...
The general prospects of several radioisotopes are reviewed; the special properties of U/sup 232/ an...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
During the purification of radioisotopes, decay periods or time dependent purification steps may be ...
In the present study, we aimed at estimating the production of medical Ac-225 radionuclide via proto...
The value of the cross-section of 226Pa production by the 232Th(p, 7n) reaction for 155 MeV protons,...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
An ion-exchange method is presented to separate the radioisotope 227Pa from a Th target after bombar...
A practical method has been developed to separate trace quantities of Pa from thorium nitrate sample...
Radiochemical separations used in large scale routine production of diagnostic and therapeutic radio...
Cross sections have been measured for the production of actinium isotopes (224 to 228) in the bombar...
The science of cancer research is currently expanding its use of alpha particle emitting radioisotop...
The general prospects of several radioisotopes are reviewed; the special properties of U/sup 232/ an...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
During the purification of radioisotopes, decay periods or time dependent purification steps may be ...
In the present study, we aimed at estimating the production of medical Ac-225 radionuclide via proto...
The value of the cross-section of 226Pa production by the 232Th(p, 7n) reaction for 155 MeV protons,...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
An ion-exchange method is presented to separate the radioisotope 227Pa from a Th target after bombar...
A practical method has been developed to separate trace quantities of Pa from thorium nitrate sample...
Radiochemical separations used in large scale routine production of diagnostic and therapeutic radio...
Cross sections have been measured for the production of actinium isotopes (224 to 228) in the bombar...
The science of cancer research is currently expanding its use of alpha particle emitting radioisotop...
The general prospects of several radioisotopes are reviewed; the special properties of U/sup 232/ an...